comparemela.com

Latest Breaking News On - Candid cream - Page 1 : comparemela.com

Glenmark Pharma reports revenue growth of 5 6 per cent YoY Q4; 12 4 per cent for the full year FY 2021-22

Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company, today announced its financial results for the fourth quarter en

Americanorth americaGlenn saldanhaEuropeglenmark europeGlenmark lifesciencesGlenmark life sciencesBiosimilars companiesGlenmark pharmaceuticals limitedGlenmark pharmaceuticalsGlenmark pharmaceuticals ltdFourth quarterNet profitPer shareManaging directorCandid creamNorth americaGlenmark europe

Glenmark Pharma reports revenue growth of 26% and PAT growth of 21% YoY for Q1 FY 2021-22

Mumbai (Maharashtra) [India], August 14 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, today announced its financial results for the first quarter ended June 30, 2021.

United statesGlenn saldanhaGlenmark europeMargin for glenmark life sciencesGlenmark life sciencesGlenmark pharmaceuticalsGlenmark pharmaceuticals limitedFirst quarterAfter taxArformoterol inhalationManaging directorConsumer careScalpe plusCandid powderConsumer care businessCandid cream

Glenmark Pharma reports revenue growth of 26%

Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, today announced its financial results for the first quarter ended Jun

United statesAmericanorth americaGlenn saldanhaLatin americaglenmarkEuropeglenmark europeMargin for glenmark life sciencesGlenmark life sciencesGlenmark pharmaceuticalsGlenmark pharmaceuticals limitedFirst quarterAfter taxArformoterol inhalationManaging directorConsumer care businesssecondaryConsumer careScalpe plus

vimarsana © 2020. All Rights Reserved.